| Ident. | Authors (with country if any) | Title |
|---|
| 000000 (2021) |
Aniruddha Singh [États-Unis] ; Muhammad S. Akbar [États-Unis] ; Doug Mcelroy [États-Unis] ; Matthew Mccurdy [États-Unis] ; Fletcher Young [États-Unis] ; Jayshree Thomas [États-Unis] ; Chrystie Nguyen [États-Unis] ; Kristopher S. Pfirman [États-Unis] | The electrocardiographic manifestations and derangements of 2019 novel coronavirus disease (COVID-19). |
| 000040 (2021) |
Nicholas Kassis [États-Unis] ; Christine Tanaka-Esposito [États-Unis] ; Roy Chung [États-Unis] ; Ankur Kalra [États-Unis] ; Mingyuan Shao [États-Unis] ; Ashish Kumar [Inde] ; Jafar Alzubi [États-Unis] ; Mina K. Chung [États-Unis] ; Umesh N. Khot [États-Unis] | Validating and implementing cardiac telemetry for continuous QTc monitoring: A novel approach to increase healthcare personnel safety during the COVID-19 pandemic. |
| 000116 (2021) |
Sathishkumar Chidambaram [Inde] ; Mohamed A. El-Sheikh [Arabie saoudite] ; Ahmed H. Alfarhan [Arabie saoudite] ; Surendrakumar Radhakrishnan [Inde] ; Idhayadhulla Akbar [Inde] | Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies. |
| 000127 (2021) |
Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar] | Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2. |
| 000264 (2021) |
Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine] | Potential inhibitors for the novel coronavirus (SARS-CoV-2). |
| 000299 (2021) |
Marko Boban [Croatie] | Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. |
| 000327 (2021) |
Yashwant Kumar Ratre [Inde] ; Namrata Kahar [Inde] ; L V K S. Bhaskar [Inde] ; Antaripa Bhattacharya [Italie] ; Henu Kumar Verma [Italie] | Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. |
| 000331 (2021) |
Haruna Isiyaku Umar [Nigeria, Inde] ; Bushra Siraj [Inde, Pakistan] ; Adeola Ajayi [Nigeria] ; Tajudeen O. Jimoh [Thaïlande, Ouganda] ; Prosper Obed Chukwuemeka [Nigeria] | Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus. |
| 000428 (2021) |
A A Kamalov [Russie] ; V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; A G Plisyk [Russie] ; Z A Akopyan [Russie] ; Yu V. Mareev [Royaume-Uni] ; E A Mershina [Russie] ; Yu L. Begrambekova [Russie] ; P V Pakhomov [Russie] | Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study. |
| 000556 (2021) |
Biswa Mohan Sahoo [Inde] ; B V V. Ravi Kumar [Inde] ; J. Sruti [Inde] ; Manoj Kumar Mahapatra [Inde] ; Bimal K. Banik [Arabie saoudite] ; Preetismita Borah [Inde] | Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. |
| 000565 (2021) |
Iwein Gyselinck [Belgique] ; Laurens Liesenborghs [Belgique] ; Ewout Landeloos [Belgique] ; Ann Belmans [Belgique] ; Geert Verbeke [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] ; W. Janssens [Belgique] | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. |
| 000688 (2021) |
Lucie Perillat [Canada] ; Brian S. Baigrie [Canada] | COVID-19 and the generation of novel scientific knowledge: Research questions and study designs. |
| 000689 (2021) |
Lucie Perillat [Canada] ; Brian S. Baigrie [Canada] | COVID-19 and the generation of novel scientific knowledge: Evidence-based decisions and data sharing. |
| 000761 (2021) |
S Udhaya Kumar [Inde] ; N Madhana Priya [Inde] ; S R Nithya [Inde] ; Priyanka Kannan [Inde] ; Nikita Jain [Inde] ; D Thirumal Kumar [Inde] ; R. Magesh [Inde] ; Salma Younes [Qatar] ; Hatem Zayed [Qatar] ; C George Priya Doss [Inde] | A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. |
| 000767 (2021) |
Yasemin Cag [Turquie] ; Sacit Icten [Turquie] ; Burcu Isik-Goren [Turquie] ; Naciye Betul Baysal [Turquie] ; Begum Bektas [Turquie] ; Ece Selvi [Turquie] ; Pinar Ergen [Turquie] ; Ozlem Aydin [Turquie] ; Ayse Canan Ucisik [Turquie] ; Fatma Yilmaz-Karadag [Turquie] ; Hulya Caskurlu [Turquie] ; Tulin Akarsu-Ayazoglu [Turquie] ; Hasan Kocoglu [Turquie] ; Sinan Uzman [Turquie] ; Muge Nural-Pamukcu [Turquie] ; Ferhat Arslan [Turquie] ; Gurhan Bas [Turquie] ; Mahmut Tayyar Kalcioglu [Turquie] ; Haluk Vahaboglu [Turquie] | A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort. |
| 000784 (2021) |
Francis Atemnkeng [États-Unis] ; Harith Alataby [États-Unis] ; Jack Demirjian [États-Unis] ; Foma Munoh Kenne [États-Unis] ; Jay Nfonoyim [États-Unis] | A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection. |
| 000906 (2020) |
Dinesh Kumar Badyal [Inde] ; Rajiv Mahajan [Inde] | Chloroquine: Can it be a Novel Drug for COVID-19. |
| 000946 (2020) |
V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; E P Pavlikova [Russie] ; S T Matskeplishvili [Russie] ; Z A Akopyan [Russie] ; A G Plisyk [Russie] ; E M Seredenina [Russie] ; D A Asratyan [Russie] ; A V Potapenko [Russie] ; P S Malakhov [Russie] ; L M Samokhodskaya [Russie] ; E A Mershina [Russie] ; V E Sinitsyn [Russie] ; M M Bulanova [Russie] ; A A Fuks [Russie] ; Yu V. Mareev [Royaume-Uni] ; Yu L. Begrambekova [Russie] ; A A Kamalov [Russie] | [Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"]. |
| 000947 (2020) |
Lenka Petroušová [République tchèque] ; Simona Da Silva ; Lud K Rožnovsk ; Irena Martinková | [Clinical progression of the first wave of novel coronavirus infection in Ostrava]. |
| 000A31 (2020) |
Begum Dariya [Inde] ; Ganji Purnachandra Nagaraju [États-Unis] | Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients. |
| 000A43 (2020) |
Khalid Shaikh [Oman] ; Chandrama Shrestha [Népal] ; Deep Dutta [Inde] | Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus. |
